| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 24 | 2017 | 429 | 4.850 |
Why?
|
| RNA-Binding Proteins | 15 | 2012 | 69 | 3.020 |
Why?
|
| Immunohistochemistry | 36 | 2017 | 497 | 2.500 |
Why?
|
| Adenocarcinoma | 15 | 2014 | 300 | 2.390 |
Why?
|
| Neoplasm Proteins | 11 | 2012 | 145 | 2.340 |
Why?
|
| Myocytes, Cardiac | 17 | 2022 | 94 | 2.170 |
Why?
|
| beta Catenin | 6 | 2019 | 36 | 1.920 |
Why?
|
| Pleural Neoplasms | 5 | 2017 | 11 | 1.760 |
Why?
|
| Carcinoid Tumor | 6 | 2013 | 13 | 1.440 |
Why?
|
| Transcription Factors | 7 | 2017 | 176 | 1.410 |
Why?
|
| Melanoma | 5 | 2015 | 165 | 1.250 |
Why?
|
| Mesothelioma | 5 | 2010 | 39 | 1.240 |
Why?
|
| Lymph Nodes | 5 | 2015 | 114 | 1.170 |
Why?
|
| Humans | 87 | 2022 | 32814 | 1.080 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2015 | 158 | 1.080 |
Why?
|
| Promoter Regions, Genetic | 7 | 2020 | 208 | 1.070 |
Why?
|
| Carcinoma, Neuroendocrine | 6 | 2011 | 13 | 1.040 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 475 | 1.010 |
Why?
|
| Carcinoma, Small Cell | 4 | 2012 | 22 | 0.990 |
Why?
|
| Lung | 10 | 2018 | 265 | 0.980 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2015 | 113 | 0.920 |
Why?
|
| Lymphatic Metastasis | 5 | 2015 | 169 | 0.910 |
Why?
|
| Myocardial Ischemia | 3 | 2020 | 105 | 0.900 |
Why?
|
| Mice | 27 | 2022 | 2512 | 0.880 |
Why?
|
| Myocardium | 11 | 2020 | 191 | 0.800 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 26 | 0.790 |
Why?
|
| Skin Neoplasms | 4 | 2009 | 217 | 0.790 |
Why?
|
| Diagnosis, Differential | 15 | 2015 | 526 | 0.780 |
Why?
|
| Histones | 2 | 2020 | 53 | 0.750 |
Why?
|
| Potassium Channels, Voltage-Gated | 7 | 2008 | 10 | 0.730 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 163 | 0.730 |
Why?
|
| Potassium Channels | 7 | 2001 | 18 | 0.710 |
Why?
|
| Mutation | 7 | 2018 | 493 | 0.700 |
Why?
|
| Heart Ventricles | 10 | 2014 | 146 | 0.690 |
Why?
|
| Animals | 34 | 2022 | 7570 | 0.690 |
Why?
|
| Heart | 5 | 2020 | 185 | 0.680 |
Why?
|
| Neuroendocrine Tumors | 4 | 2015 | 19 | 0.660 |
Why?
|
| Sarcoma, Endometrial Stromal | 2 | 2011 | 3 | 0.650 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 142 | 0.630 |
Why?
|
| Specimen Handling | 2 | 2019 | 31 | 0.610 |
Why?
|
| Membrane Potentials | 5 | 2019 | 80 | 0.610 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2022 | 101 | 0.610 |
Why?
|
| Sulfonamides | 1 | 2019 | 67 | 0.600 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2018 | 949 | 0.590 |
Why?
|
| Frozen Sections | 1 | 2019 | 18 | 0.590 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 9 | 0.590 |
Why?
|
| Female | 38 | 2020 | 20271 | 0.580 |
Why?
|
| Shal Potassium Channels | 5 | 2015 | 7 | 0.580 |
Why?
|
| Mediastinal Neoplasms | 2 | 2009 | 13 | 0.580 |
Why?
|
| Aged | 27 | 2020 | 10544 | 0.560 |
Why?
|
| Pulmonary Sclerosing Hemangioma | 1 | 2017 | 1 | 0.550 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 76 | 0.550 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 70 | 0.550 |
Why?
|
| Pancreatic Neoplasms | 4 | 2012 | 129 | 0.540 |
Why?
|
| Adult | 28 | 2020 | 9569 | 0.530 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 647 | 0.520 |
Why?
|
| Liver Neoplasms | 3 | 2012 | 154 | 0.500 |
Why?
|
| Male | 38 | 2020 | 19650 | 0.490 |
Why?
|
| RNA, Messenger | 5 | 2022 | 498 | 0.480 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2013 | 32 | 0.480 |
Why?
|
| Kv Channel-Interacting Proteins | 2 | 2015 | 2 | 0.480 |
Why?
|
| Salivary Ducts | 1 | 2015 | 2 | 0.470 |
Why?
|
| Mucins | 1 | 2015 | 17 | 0.470 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2013 | 78 | 0.470 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2015 | 13 | 0.470 |
Why?
|
| Patch-Clamp Techniques | 9 | 2016 | 75 | 0.460 |
Why?
|
| Giant Cell Tumors | 1 | 2015 | 4 | 0.460 |
Why?
|
| Parietal Lobe | 1 | 2015 | 13 | 0.460 |
Why?
|
| Brugada Syndrome | 1 | 2015 | 18 | 0.460 |
Why?
|
| Antibodies, Monoclonal | 3 | 2013 | 240 | 0.450 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2011 | 4 | 0.440 |
Why?
|
| Pleural Effusion, Malignant | 3 | 2010 | 8 | 0.430 |
Why?
|
| Serpins | 2 | 2013 | 6 | 0.430 |
Why?
|
| Signal Transduction | 8 | 2019 | 687 | 0.410 |
Why?
|
| Glioblastoma | 1 | 2015 | 157 | 0.400 |
Why?
|
| Middle Aged | 24 | 2020 | 12133 | 0.400 |
Why?
|
| Nevus | 3 | 2009 | 15 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2011 | 32 | 0.400 |
Why?
|
| Cell Line | 9 | 2019 | 433 | 0.390 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2012 | 6 | 0.380 |
Why?
|
| Action Potentials | 7 | 2014 | 186 | 0.380 |
Why?
|
| DNA Mutational Analysis | 4 | 2017 | 71 | 0.380 |
Why?
|
| Neoplasm Invasiveness | 3 | 2012 | 193 | 0.380 |
Why?
|
| Sodium Channels | 1 | 2012 | 16 | 0.370 |
Why?
|
| Aged, 80 and over | 14 | 2020 | 4034 | 0.360 |
Why?
|
| Mediastinum | 2 | 2009 | 14 | 0.360 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 888 | 0.350 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 48 | 0.340 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 8 | 0.340 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2010 | 2 | 0.340 |
Why?
|
| Sarcoma, Synovial | 1 | 2010 | 6 | 0.340 |
Why?
|
| Cell Nucleus | 3 | 2019 | 105 | 0.330 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2015 | 22 | 0.330 |
Why?
|
| Hydrogen Peroxide | 5 | 2016 | 84 | 0.330 |
Why?
|
| CA-125 Antigen | 1 | 2010 | 6 | 0.330 |
Why?
|
| Caveolin 3 | 2 | 2022 | 2 | 0.330 |
Why?
|
| Sarcoma | 3 | 2019 | 71 | 0.320 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 483 | 0.320 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 98 | 0.310 |
Why?
|
| Meningeal Neoplasms | 1 | 2010 | 50 | 0.310 |
Why?
|
| Fibroma | 1 | 2009 | 10 | 0.310 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2009 | 71 | 0.300 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2009 | 5 | 0.300 |
Why?
|
| Leiomyoma | 1 | 2009 | 15 | 0.300 |
Why?
|
| Parathyroid Neoplasms | 1 | 2009 | 7 | 0.290 |
Why?
|
| Fractures, Spontaneous | 1 | 2008 | 15 | 0.290 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 29 | 0.290 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2008 | 9 | 0.290 |
Why?
|
| Membrane Proteins | 1 | 2010 | 251 | 0.290 |
Why?
|
| Femoral Neck Fractures | 1 | 2008 | 12 | 0.290 |
Why?
|
| Pleural Effusion | 1 | 2008 | 13 | 0.280 |
Why?
|
| Carcinoma, Large Cell | 1 | 2007 | 3 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 24 | 0.270 |
Why?
|
| Biopsy | 4 | 2017 | 245 | 0.270 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2017 | 17 | 0.260 |
Why?
|
| Malacoplakia | 1 | 2007 | 1 | 0.260 |
Why?
|
| Inclusion Bodies | 1 | 2007 | 2 | 0.260 |
Why?
|
| Bone Neoplasms | 1 | 2008 | 117 | 0.260 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1012 | 0.260 |
Why?
|
| Peritoneal Neoplasms | 1 | 2010 | 263 | 0.260 |
Why?
|
| Pneumonectomy | 2 | 2017 | 14 | 0.250 |
Why?
|
| Mice, Transgenic | 9 | 2019 | 258 | 0.250 |
Why?
|
| Prostate | 1 | 2007 | 69 | 0.250 |
Why?
|
| Ventricular Remodeling | 2 | 2022 | 64 | 0.240 |
Why?
|
| Cell Differentiation | 3 | 2019 | 468 | 0.240 |
Why?
|
| Rats | 9 | 2022 | 1606 | 0.230 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2016 | 20 | 0.230 |
Why?
|
| Cysteine Endopeptidases | 3 | 2012 | 5 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2015 | 71 | 0.230 |
Why?
|
| Cells, Cultured | 8 | 2016 | 820 | 0.230 |
Why?
|
| Papilloma | 1 | 2004 | 8 | 0.220 |
Why?
|
| Positron-Emission Tomography | 3 | 2015 | 167 | 0.220 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 16 | 0.220 |
Why?
|
| Thyroid Neoplasms | 2 | 2018 | 33 | 0.220 |
Why?
|
| Papillomaviridae | 1 | 2004 | 22 | 0.220 |
Why?
|
| YY1 Transcription Factor | 2 | 2015 | 6 | 0.200 |
Why?
|
| Neoplasms | 1 | 2010 | 762 | 0.200 |
Why?
|
| Mice, Knockout | 7 | 2016 | 453 | 0.200 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 52 | 0.190 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2022 | 2 | 0.190 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 16 | 0.190 |
Why?
|
| Genes, Dominant | 2 | 1999 | 27 | 0.190 |
Why?
|
| Hyperplasia | 3 | 2014 | 39 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2014 | 471 | 0.190 |
Why?
|
| Cardiomegaly | 3 | 2022 | 31 | 0.180 |
Why?
|
| Pulmonary Valve | 1 | 2001 | 11 | 0.180 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2012 | 12 | 0.180 |
Why?
|
| Exons | 2 | 2019 | 52 | 0.170 |
Why?
|
| Bile Duct Neoplasms | 2 | 2012 | 32 | 0.170 |
Why?
|
| Adolescent | 8 | 2013 | 3640 | 0.170 |
Why?
|
| Blotting, Western | 5 | 2015 | 287 | 0.170 |
Why?
|
| Calcium | 4 | 2022 | 323 | 0.170 |
Why?
|
| Precancerous Conditions | 3 | 2010 | 25 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 255 | 0.160 |
Why?
|
| RNA, Small Interfering | 2 | 2022 | 113 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2012 | 2 | 0.160 |
Why?
|
| Ventricular Function | 3 | 2012 | 8 | 0.160 |
Why?
|
| Ovarian Neoplasms | 2 | 2013 | 103 | 0.160 |
Why?
|
| Papillomavirus Infections | 2 | 2015 | 68 | 0.160 |
Why?
|
| Laryngeal Neoplasms | 1 | 2019 | 16 | 0.160 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 19 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 18 | 0.150 |
Why?
|
| Binding Sites | 2 | 2016 | 129 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2019 | 13 | 0.150 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2018 | 8 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2019 | 99 | 0.150 |
Why?
|
| Cardiotonic Agents | 2 | 2017 | 43 | 0.150 |
Why?
|
| Radiography | 2 | 2011 | 386 | 0.150 |
Why?
|
| Oxidants | 3 | 2015 | 15 | 0.150 |
Why?
|
| Airway Obstruction | 2 | 2010 | 32 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 98 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 102 | 0.150 |
Why?
|
| Reoperation | 2 | 2015 | 260 | 0.140 |
Why?
|
| Pleura | 2 | 2008 | 2 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2010 | 61 | 0.140 |
Why?
|
| Gastrointestinal Tract | 2 | 2020 | 31 | 0.140 |
Why?
|
| Thoracotomy | 2 | 2015 | 25 | 0.140 |
Why?
|
| RNA Interference | 3 | 2016 | 77 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2022 | 134 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 65 | 0.130 |
Why?
|
| Actins | 2 | 2015 | 51 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2017 | 48 | 0.130 |
Why?
|
| Neoplasms, Fibrous Tissue | 1 | 2007 | 2 | 0.130 |
Why?
|
| Haemophilus Infections | 2 | 2007 | 8 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 7 | 2012 | 789 | 0.130 |
Why?
|
| Haemophilus influenzae | 2 | 2007 | 14 | 0.130 |
Why?
|
| Electrocardiography | 5 | 2014 | 636 | 0.130 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2008 | 52 | 0.130 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2017 | 18 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 22 | 0.130 |
Why?
|
| Propofol | 1 | 2017 | 20 | 0.130 |
Why?
|
| Prognosis | 3 | 2010 | 1545 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 1996 | 20 | 0.130 |
Why?
|
| Cyclic AMP Response Element Modulator | 2 | 2007 | 2 | 0.120 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2007 | 3 | 0.120 |
Why?
|
| Lithium Chloride | 1 | 2016 | 2 | 0.120 |
Why?
|
| Gene Expression | 4 | 2012 | 334 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 28 | 0.120 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 576 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 2 | 2007 | 43 | 0.120 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2015 | 1 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 727 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2015 | 16 | 0.120 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 9 | 0.120 |
Why?
|
| Electrophysiology | 4 | 1999 | 72 | 0.120 |
Why?
|
| DNA Repair | 1 | 2015 | 57 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 44 | 0.110 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 95 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 2 | 2015 | 10 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2015 | 28 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2015 | 603 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 43 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2015 | 96 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 767 | 0.110 |
Why?
|
| Intestinal Polyps | 1 | 2014 | 4 | 0.110 |
Why?
|
| Colonic Polyps | 1 | 2014 | 14 | 0.110 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2014 | 1 | 0.110 |
Why?
|
| Connexin 43 | 1 | 2014 | 5 | 0.110 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 21 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2017 | 754 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 51 | 0.110 |
Why?
|
| Hela Cells | 2 | 2012 | 80 | 0.110 |
Why?
|
| Apoptosis | 2 | 2007 | 362 | 0.110 |
Why?
|
| Pneumococcal Infections | 2 | 2012 | 32 | 0.110 |
Why?
|
| Adenoma | 1 | 2014 | 35 | 0.110 |
Why?
|
| Neurosecretory Systems | 1 | 2014 | 2 | 0.110 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 92 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 24 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 11 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2014 | 19 | 0.110 |
Why?
|
| Liver | 2 | 2020 | 492 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2015 | 239 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2014 | 29 | 0.100 |
Why?
|
| Long QT Syndrome | 2 | 2008 | 46 | 0.100 |
Why?
|
| Esophageal Motility Disorders | 1 | 2013 | 6 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 14 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2010 | 18 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 65 | 0.100 |
Why?
|
| Mucous Membrane | 1 | 2013 | 21 | 0.100 |
Why?
|
| Constipation | 1 | 2013 | 11 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2013 | 63 | 0.100 |
Why?
|
| Chromogranins | 1 | 2012 | 2 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2012 | 4 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 1307 | 0.100 |
Why?
|
| Antibodies | 1 | 2013 | 51 | 0.100 |
Why?
|
| Prostatic Neoplasms | 2 | 2008 | 476 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 47 | 0.100 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 12 | 0.090 |
Why?
|
| Bile Ducts | 1 | 2012 | 20 | 0.090 |
Why?
|
| Aorta, Abdominal | 1 | 2012 | 29 | 0.090 |
Why?
|
| Up-Regulation | 5 | 2016 | 191 | 0.090 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2012 | 18 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 384 | 0.090 |
Why?
|
| Ventricular Dysfunction | 1 | 2012 | 4 | 0.090 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2012 | 18 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 27 | 0.090 |
Why?
|
| Response Elements | 1 | 2012 | 17 | 0.090 |
Why?
|
| Diabetic Angiopathies | 1 | 2012 | 145 | 0.090 |
Why?
|
| Pericardium | 1 | 2012 | 55 | 0.090 |
Why?
|
| Glypicans | 1 | 2011 | 1 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 222 | 0.090 |
Why?
|
| Hamartoma | 1 | 2011 | 10 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 5 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2012 | 48 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2007 | 265 | 0.090 |
Why?
|
| Protein Binding | 1 | 2012 | 200 | 0.090 |
Why?
|
| Base Sequence | 1 | 2012 | 247 | 0.090 |
Why?
|
| Neprilysin | 1 | 2011 | 31 | 0.090 |
Why?
|
| Keratins | 1 | 2011 | 37 | 0.090 |
Why?
|
| Heart Failure | 2 | 2016 | 695 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2011 | 57 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2008 | 133 | 0.090 |
Why?
|
| Cardiomyopathies | 2 | 2017 | 66 | 0.090 |
Why?
|
| Mitochondria, Heart | 2 | 2022 | 18 | 0.080 |
Why?
|
| Neuroendocrine Cells | 1 | 2010 | 1 | 0.080 |
Why?
|
| Adenoma, Liver Cell | 1 | 2010 | 1 | 0.080 |
Why?
|
| Cholangiocarcinoma | 1 | 2010 | 11 | 0.080 |
Why?
|
| Kinetics | 3 | 2019 | 206 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 20 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 60 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2010 | 14 | 0.080 |
Why?
|
| Lymphoma | 1 | 2010 | 33 | 0.080 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2010 | 5 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 80 | 0.080 |
Why?
|
| Feedback, Physiological | 2 | 2007 | 10 | 0.080 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2009 | 3 | 0.080 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Calmodulin | 1 | 2009 | 2 | 0.080 |
Why?
|
| Second Messenger Systems | 1 | 2009 | 6 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2015 | 226 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2009 | 46 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2010 | 136 | 0.080 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2009 | 2 | 0.070 |
Why?
|
| Hyperparathyroidism | 1 | 2009 | 9 | 0.070 |
Why?
|
| Pneumonia, Lipid | 1 | 2008 | 1 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2008 | 24 | 0.070 |
Why?
|
| Crack Cocaine | 1 | 2008 | 4 | 0.070 |
Why?
|
| Petrolatum | 1 | 2008 | 4 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2001 | 107 | 0.070 |
Why?
|
| Lymphocytes | 1 | 2009 | 59 | 0.070 |
Why?
|
| Electric Conductivity | 2 | 1999 | 10 | 0.070 |
Why?
|
| Urologic Neoplasms | 1 | 2008 | 14 | 0.070 |
Why?
|
| Ascitic Fluid | 1 | 2008 | 5 | 0.070 |
Why?
|
| Potassium | 2 | 1999 | 40 | 0.070 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 9 | 0.070 |
Why?
|
| Fibroblasts | 3 | 2015 | 114 | 0.070 |
Why?
|
| Urothelium | 1 | 2008 | 55 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 199 | 0.070 |
Why?
|
| Ear, Middle | 1 | 2007 | 9 | 0.070 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2007 | 12 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 98 | 0.070 |
Why?
|
| Isoproterenol | 2 | 2022 | 17 | 0.070 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2007 | 2 | 0.070 |
Why?
|
| Tissue Array Analysis | 3 | 2015 | 36 | 0.070 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 22 | 0.070 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2007 | 1 | 0.060 |
Why?
|
| Gastritis | 1 | 2007 | 4 | 0.060 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2006 | 1 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 220 | 0.060 |
Why?
|
| Pyelonephritis | 1 | 2007 | 9 | 0.060 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2006 | 8 | 0.060 |
Why?
|
| Pneumocystis Infections | 1 | 2006 | 2 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2012 | 788 | 0.060 |
Why?
|
| Inflammation | 2 | 2007 | 536 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 23 | 0.060 |
Why?
|
| Muscle Contraction | 2 | 2019 | 113 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 73 | 0.060 |
Why?
|
| Disease Progression | 1 | 2008 | 594 | 0.060 |
Why?
|
| Dilatation, Pathologic | 2 | 2003 | 20 | 0.060 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2004 | 10 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2004 | 10 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 33 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2004 | 54 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2004 | 54 | 0.050 |
Why?
|
| Observer Variation | 2 | 2015 | 96 | 0.050 |
Why?
|
| China | 2 | 2014 | 54 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2013 | 1282 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 90 | 0.050 |
Why?
|
| Aorta | 1 | 2003 | 127 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2003 | 62 | 0.050 |
Why?
|
| Reperfusion | 1 | 2022 | 21 | 0.050 |
Why?
|
| Lysine | 1 | 2022 | 23 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3705 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2022 | 45 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2002 | 3 | 0.050 |
Why?
|
| Risk Factors | 1 | 2010 | 3976 | 0.050 |
Why?
|
| Ischemia | 1 | 2022 | 104 | 0.050 |
Why?
|
| Endocarditis | 1 | 2002 | 18 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2001 | 27 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2001 | 84 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2001 | 60 | 0.040 |
Why?
|
| Child | 3 | 2013 | 2478 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2014 | 877 | 0.040 |
Why?
|
| Washington | 1 | 2020 | 7 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 12 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 19 | 0.040 |
Why?
|
| Autopsy | 1 | 2020 | 33 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 49 | 0.040 |
Why?
|
| Transfection | 2 | 2016 | 184 | 0.040 |
Why?
|
| Trachea | 1 | 2020 | 52 | 0.040 |
Why?
|
| Spleen | 1 | 2020 | 85 | 0.040 |
Why?
|
| Kidney | 2 | 2020 | 520 | 0.040 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 1999 | 1 | 0.040 |
Why?
|
| Shab Potassium Channels | 1 | 1999 | 2 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 2 | 2012 | 40 | 0.040 |
Why?
|
| Thrombosis | 1 | 2020 | 81 | 0.040 |
Why?
|
| Hypertension | 1 | 2007 | 976 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 14 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 26 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 1999 | 4 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 15 | 0.040 |
Why?
|
| Acetylation | 2 | 2011 | 16 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2002 | 828 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 1999 | 59 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2019 | 1 | 0.040 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Smad Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 7 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 1999 | 89 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2010 | 83 | 0.040 |
Why?
|
| Heart Atria | 1 | 1999 | 78 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 267 | 0.040 |
Why?
|
| Diastole | 2 | 2012 | 97 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 1462 | 0.040 |
Why?
|
| Glucose | 2 | 2012 | 184 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 187 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 2017 | 4 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2017 | 16 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2007 | 58 | 0.030 |
Why?
|
| Time Factors | 2 | 1999 | 2183 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 1996 | 3 | 0.030 |
Why?
|
| Elapid Venoms | 1 | 1996 | 2 | 0.030 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1996 | 4 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 1996 | 47 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2004 | 3441 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1996 | 15 | 0.030 |
Why?
|
| Pancreas | 1 | 2007 | 103 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 2734 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 2 | 2007 | 2 | 0.030 |
Why?
|
| Desmin | 1 | 2016 | 12 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1996 | 67 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 229 | 0.030 |
Why?
|
| Luciferases | 2 | 2007 | 31 | 0.030 |
Why?
|
| Cyclins | 1 | 2015 | 6 | 0.030 |
Why?
|
| Cell Shape | 1 | 2015 | 28 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 28 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 65 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 71 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 134 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1998 | 403 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2007 | 381 | 0.030 |
Why?
|
| Polyps | 1 | 2014 | 9 | 0.030 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2014 | 6 | 0.030 |
Why?
|
| Butadienes | 1 | 2014 | 8 | 0.030 |
Why?
|
| Lead | 1 | 2014 | 6 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2014 | 42 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2014 | 11 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 154 | 0.030 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2014 | 28 | 0.030 |
Why?
|
| Nitriles | 1 | 2014 | 23 | 0.030 |
Why?
|
| Colon | 1 | 2014 | 51 | 0.030 |
Why?
|
| Age Factors | 1 | 1996 | 1197 | 0.020 |
Why?
|
| Ovary | 1 | 2013 | 58 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2013 | 13 | 0.020 |
Why?
|
| Buffers | 1 | 2013 | 10 | 0.020 |
Why?
|
| Genes, erbB-1 | 1 | 2013 | 14 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 72 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2012 | 3 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 69 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2012 | 6 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 316 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 64 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 35 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 30 | 0.020 |
Why?
|
| Endoscopy | 1 | 2012 | 56 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 16 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2007 | 862 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 156 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 122 | 0.020 |
Why?
|
| Mediastinoscopy | 1 | 2010 | 1 | 0.020 |
Why?
|
| Thoracic Cavity | 1 | 2010 | 2 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 82 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 28 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 295 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2009 | 13 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 213 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 80 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 163 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2009 | 245 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1083 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2007 | 1 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2007 | 4 | 0.020 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Streptolysins | 1 | 2007 | 2 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 36 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 2329 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2007 | 8 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 18 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 31 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2007 | 10 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2007 | 20 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 89 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 82 | 0.020 |
Why?
|
| United States | 1 | 2015 | 4109 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2006 | 100 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2006 | 18 | 0.020 |
Why?
|
| Pneumocystis carinii | 1 | 2006 | 6 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 32 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2006 | 71 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2007 | 84 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2005 | 20 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 97 | 0.010 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2004 | 1 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2004 | 29 | 0.010 |
Why?
|
| Genomics | 1 | 2005 | 88 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 36 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 68 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 105 | 0.010 |
Why?
|
| Elasticity | 1 | 2003 | 38 | 0.010 |
Why?
|
| Heart Rate | 1 | 2005 | 343 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 96 | 0.010 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2001 | 1 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2002 | 28 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2001 | 14 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 26 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 72 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2001 | 79 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2002 | 81 | 0.010 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 1999 | 1 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 28 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 511 | 0.010 |
Why?
|